Ethema Health Corporation
GRST · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,017 | $5,345 | $4,821 | $1,943 |
| % Growth | 12.6% | 10.9% | 148.1% | – |
| Cost of Goods Sold | $0 | $676 | $1,159 | $179 |
| Gross Profit | $6,017 | $4,669 | $3,662 | $1,764 |
| % Margin | 100% | 87.4% | 76% | 90.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6,883 | $5,020 | $3,792 | $1,615 |
| SG&A Expenses | $6,883 | $5,020 | $3,792 | $1,615 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $467 | $867 | -$619 | $147 |
| Operating Expenses | $7,350 | $5,887 | $3,173 | $1,762 |
| Operating Income | -$1,333 | -$542 | $489 | $2 |
| % Margin | -22.2% | -10.1% | 10.1% | 0.1% |
| Other Income/Exp. Net | -$833 | $1,156 | -$82 | -$1,856 |
| Pre-Tax Income | -$2,166 | $614 | $407 | -$1,854 |
| Tax Expense | $0 | -$392 | $112 | -$281 |
| Net Income | -$2,064 | $1,177 | $248 | -$1,543 |
| % Margin | -34.3% | 22% | 5.1% | -79.4% |
| EPS | -0 | 0 | 0 | -0.001 |
| % Growth | -200% | 200% | 116.7% | – |
| EPS Diluted | -0 | 0 | 0 | -0.001 |
| Weighted Avg Shares Out | 7,207,315 | 3,729,054 | 3,704,807 | 2,701,590 |
| Weighted Avg Shares Out Dil | 7,207,315 | 3,903,672 | 3,704,807 | 2,701,590 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $0 | $0 |
| Interest Expense | $981 | $782 | $1,213 | $2,795 |
| Depreciation & Amortization | $614 | $676 | $801 | $444 |
| EBITDA | -$570 | $2,072 | $2,421 | $1,385 |
| % Margin | -9.5% | 38.8% | 50.2% | 71.3% |